MASH

Metabolic dysfunction-associated steatohepatitis (MASH), previously known as nonalcoholic steatohepatitis (NASH).

ChatGPT said Low-poly magenta liver model centered on a pale blue background patterned with sketchy dollar signs suggestin
Favicon Fierce Pharma

Big Pharma bets big on MASH with a new combo playbook

GSK, Roche and Novo jumped into MASH with a multibillion-dollar deal spree. Now, the phase 3 data have to deliver.
Ayla Ellison Oct 17, 2025 9:30am
Graphic of two hands shaking under a red and purple light

Novo inks $4.7B Akero buyout to bag late-phase MASH prospect

Oct 9, 2025 8:21am
three triple doors opportunity cracked open ajar

89bio was left between a Roche and a hard place in buyout talks

Oct 2, 2025 9:55am
liver

Roche becomes MASH player via $3.5B deal for 89bio, ph. 3 drug

Sep 18, 2025 5:02am
liver

FDA considers new liver trial endpoint, sending MASH shares up

Aug 28, 2025 11:25am
Person throwing piece of paper into full waste bin

Gilead culls last MASH program, 2 cancer assets

Aug 8, 2025 11:50am